| Literature DB >> 34462753 |
Julia S Sobolik, Elizabeth T Sajewski, Lee-Ann Jaykus, D Kane Cooper, Ben A Lopman, Alicia Nm Kraay, P Barry Ryan, Jodie L Guest, Amy Webb-Girard, Juan S Leon.
Abstract
BACKGROUND: Countries continue to debate the need for decontamination of cold-chain food packaging to reduce possible SARS-CoV-2 fomite transmission among workers. While laboratory-based studies demonstrate persistence of SARS-CoV-2 on surfaces, the likelihood of fomite-mediated transmission under real-life conditions is uncertain.Entities:
Year: 2021 PMID: 34462753 PMCID: PMC8404890 DOI: 10.1101/2021.08.23.21262477
Source DB: PubMed Journal: medRxiv
Figure 1.Conceptual framework for fomite-mediated SARS-CoV-2 transmission involving exposure of a susceptible worker to individual plastic cartons, palletized cartons, and plastic wrap in a receiving warehouse under cold-chain conditions. This schematic depicts a representative frozen food packaging facility, initiating with two infected workers (left panel). Up to 10 contamination events per infected worker (0 to 10 coughs) can occur at three stages in the packaging pipeline: 1) contamination of the top-face of individual plastic cartons (144-216 individual cartons processed per hour) via respiratory droplet and aerosol fallout from the first infected worker while cartons are transported along a conveyor belt (orange in schematic); 2) contamination of cartons via respiratory particle spray (droplets and aerosols) as cartons are placed (manually or via automation) on a pallet by the second infected worker (yellow in schematic); and 3) contamination of the plastic-wrapped palletized cartons by respiratory particle spray (droplet and aerosol) from the second infected worker (yellow in schematic). Four pallets, each containing approximately 36-54 individual plastic cartons, are processed per hour. Because of current Good Manufacturing Practices (cGMP), the model did not account for indirect transfer of virus from the infected workers’ hands to the plastic fomites along the packaging pipeline. Under cold-chain conditions assuming no viral decay, plastic wrapped pallets were transported to a receiving warehouse for unloading by a susceptible worker. Infection risks resulting exclusively from fomite transmission were simulated as contacts between the susceptible worker’s fingers and palms (of both hands) and the fomite surface (accounting for the surface area of the hand relative to the fomite surface); virus transfer from fomite to hands; and virus transfer from fingertips to facial mucous membranes (accounting for the surface area of the fingers relative to the combined surface area of the eyes, nose, and mouth). Grey boxes indicate infection control measures implemented for the infected (mask use, vaccination) and susceptible (handwashing, mask use, vaccination) workers. In the scenarios with additional plastic surface decontamination, this was simulated prior to the susceptible worker contacting the fomites.
Figure 2.Fomite-mediated SARS-CoV-2 infection risks associated with individual and combined standard infection control measures (hourly handwashing [2 log10 virus removal efficiency],[58] surgical mask use). Vaccination was incorporated into the model representing two doses of mRNA vaccine (Moderna/Pfizer) and was applied with and without the standard infection control measures. Additional decontamination of plastic packaging [3 log10 virus removal efficiency][59] was applied in combination with the standard infection control measures. Ventilation (two air changes per hour [ACH]) was applied to all simulations. An infectious to non-infectious particle ratio of 1:100[41] was applied to all viral shedding concentrations. Reductions in SARS-CoV-2 infection risk (%) to the susceptible worker relative to no interventions are reported below each panel. Panel A represents the impact of standard infection control measures with and without vaccination on fomite-mediated SARS-CoV-2 risk. For the first vaccination scenario, we assumed only the susceptible worker was vaccinated with two doses of mRNA vaccine (Moderna/Pfizer) and vaccine effectiveness (VE) against susceptibility to infection was simulated across three vaccination states. These included: 1) no vaccination/no prior immunity; 2) lower VE ranging from 64[86]-80%[87] representative of reduced protection (variants of concern, waning immunity, immunocompromised and elderly or at-risk populations); and 3) optimal VE ranging from 86%[88,89]-99[90]% among healthy adults 14 days or more after second mRNA dose. Panel B: the second vaccine scenario represented vaccine effectiveness against transmission, where all workers are assumed to be vaccinated with two doses of mRNA vaccines and hence the model simulated rare breakthrough infections. Vaccine effectiveness against transmission (VET) was modeled by applying the combined effect of the reduction in risk of infection to the susceptible worker and the risk of transmissibility given a rare breakthrough infection among the vaccinated workers. We used the VET estimate (88·5% [95% CI: 82·3%, 94·8%] derived from Prunas et al.,[62] VET was modeled across a range of three peak infectious viral shedding concentrations representative of possible increased transmissibility and/or infectiousness of variants of concern: 1) 8·1-9·4 log10 viral particles; 2) 7·1-8·4 log10 viral particles; and 3) 6·4-7·7 log10 viral particles. These viral shedding levels represent 100-, 10-, and 2-times, respectively, the increased viral shedding concentration simulated in the base model analysis. Dashed lines represent 1:10,000 (black) and 1:1,000,000 (grey) infection risk thresholds, derived from WHO and U.S. EPA guidelines for drinking water quality.[60,61]